Dr Reddy's gets EIR from USFDA for Cuernavaca plant in Mexico

The company had earlier said in a regulatory filing that audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico by the USFDA was completed with zero observations.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news